Abiopharma

Global Technologies, LTD (OTC: GTLL) Issues Formal Confirmation of SEC Reporting Status and Completion of Independent Two-Year Audit

Visa將為Canton Network提供隱私保護支付功能

2025 Financial Results and Ongoing Clinical Progress Highlighting Positive Data in Phase 2a Pancreatic cancer and 9 Years Cancer-Free Survival in Liver Cancer Patient

20F FOR 2025

FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair

Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment

Visa führt datenschutzkonforme Zahlungsmethoden im Canton Network ein

Draganfly Provides Corporate Update Highlighting Strong Defense Momentum, Industry Tailwinds, and Robust Balance Sheet

VivoPower Receives Nasdaq Approval of Ticker “TEMB” for Planned Tembo Listing at a Targeted Valuation of $838 Million

Visa s’apprête à apporter des solutions de paiement préservant la confidentialité au Canton Network